|
1.陳景德: 肝膽疾病學. 1974.
2.Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ: Mechanisms of hepatotoxicity. Toxicol Sci 2002, 65(2):166-176.
3.Patel T, Roberts LR, Jones BA, Gores GJ: Dysregulation of apoptosis as a mechanism of liver disease: an overview. Semin Liver Dis 1998, 18(2):105-114.
4.Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ: A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998, 101(12):2790-2799.
5.Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan K, Childs S, Ling V et al: A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998, 20(3):233-238.
6.Patel T, Bronk SF, Gores GJ: Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest 1994, 94(6):2183-2192.
7.Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26(4):239-257.
8.Wyllie AH, Morris RG, Smith AL, Dunlop D: Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984, 142(1):67-77.
9.Green DR: Apoptotic pathways: the roads to ruin. Cell 1998, 94(6):695-698.
10.Faubion WA, Gores GJ: Death receptors in liver biology and pathobiology. Hepatology 1999, 29(1):1-4.
11.Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, Svingen PA, Kaufmann SH, Gores GJ: Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999, 103(1):137-145.
12.Miyoshi H, Rust C, Roberts PJ, Burgart LJ, Gores GJ: Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 1999, 117(3):669-677.
13.Sodeman T, Bronk SF, Roberts PJ, Miyoshi H, Gores GJ: Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol 2000, 278(6):G992-999.
14.Jaeschke H, Smith CW: Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 1997, 61(6):647-653.
15.Jaeschke H, Smith CW, Clemens MG, Ganey PE, Roth RA: Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils. Toxicol Appl Pharmacol 1996, 139(2):213-226.
16.Laskin DL, Laskin JD: Role of macrophages and inflammatory mediators in chemically induced toxicity. Toxicology 2001, 160(1-3):111-118.
17.Lawson JA, Farhood A, Hopper RD, Bajt ML, Jaeschke H: The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci 2000, 54(2):509-516.
18.Maher JJ, Scott MK, Saito JM, Burton MC: Adenovirus-mediated expression of cytokine-induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis. Hepatology 1997, 25(3):624-630.
19.Jaeschke H: Cellular adhesion molecules: regulation and functional significance in the pathogenesis of liver diseases. Am J Physiol 1997, 273(3 Pt 1):G602-611.
20.Chosay JG, Essani NA, Dunn CJ, Jaeschke H: Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury. Am J Physiol 1997, 272(5 Pt 1):G1195-1200.
21.Essani NA, Fisher MA, Farhood A, Manning AM, Smith CW, Jaeschke H: Cytokine-induced upregulation of hepatic intercellular adhesion molecule-1 messenger RNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure. Hepatology 1995, 21(6):1632-1639.
22.Essani NA, Bajt ML, Farhood A, Vonderfecht SL, Jaeschke H: Transcriptional activation of vascular cell adhesion molecule-1 gene in vivo and its role in the pathophysiology of neutrophil-induced liver injury in murine endotoxin shock. J Immunol 1997, 158(12):5941-5948.
23.Lawson JA, Burns AR, Farhood A, Lynn Bajt M, Collins RG, Smith CW, Jaeschke H: Pathophysiologic importance of E- and L-selectin for neutrophil-induced liver injury during endotoxemia in mice. Hepatology 2000, 32(5):990-998.
24.Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ, Smith CW: Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology 1993, 17(5):915-923.
25.Curzio M, Esterbauer H, Di Mauro C, Cecchini G, Dianzani MU: Chemotactic activity of the lipid peroxidation product 4-hydroxynonenal and homologous hydroxyalkenals. Biol Chem Hoppe Seyler 1986, 367(4):321-329.
26.Liu P, Vonderfecht SL, McGuire GM, Fisher MA, Farhood A, Jaeschke H: The 21-aminosteroid tirilazad mesylate protects against endotoxin shock and acute liver failure in rats. J Pharmacol Exp Ther 1994, 271(1):438-445.
27.Jaeschke H, Ho YS, Fisher MA, Lawson JA, Farhood A: Glutathione peroxidase-deficient mice are more susceptible to neutrophil-mediated hepatic parenchymal cell injury during endotoxemia: importance of an intracellular oxidant stress. Hepatology 1999, 29(2):443-450.
28.Jaeschke H: Reactive oxygen and mechanisms of inflammatory liver injury. J Gastroenterol Hepatol 2000, 15(7):718-724.
29.Fubini B, Hubbard A: Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med 2003, 34(12):1507-1516.
30.Armstrong D: Free radical and antioxidant protocols. Introduction. Methods Mol Biol 1998, 108:v-viii.
31.Halliwell B: Oxygen and nitrogen are pro-carcinogens. Damage to DNA by reactive oxygen, chlorine and nitrogen species: measurement, mechanism and the effects of nutrition. Mutat Res 1999, 443(1-2):37-52.
32.Vertuani S, Angusti A, Manfredini S: The antioxidants and pro-antioxidants network: an overview. Curr Pharm Des 2004, 10(14):1677-1694.
33.Cai J, Jones DP: Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J Biol Chem 1998, 273(19):11401-11404.
34.Wong GH, Elwell JH, Oberley LW, Goeddel DV: Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989, 58(5):923-931.
35.Mayer M, Noble M: N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci U S A 1994, 91(16):7496-7500.
36.Liu TZ, Lee KT, Chern CL, Cheng JT, Stern A, Tsai LY: Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappaB. Ann Clin Lab Sci 2001, 31(4):383-390.
37.Yerushalmi B, Dahl R, Devereaux MW, Gumpricht E, Sokol RJ: Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology 2001, 33(3):616-626.
38.Padillo FJ, Cruz A, Navarrete C, Bujalance I, Briceno J, Gallardo JI, Marchal T, Caballero R, Tunez I, Muntane J et al: Melatonin prevents oxidative stress and hepatocyte cell death induced by experimental cholestasis. Free Radic Res 2004, 38(7):697-704.
39.Cruz A, Padillo FJ, Tunez I, Munoz C, Granados J, Pera-Madrazo C, Montilla P: Melatonin protects against renal oxidative stress after obstructive jaundice in rats. Eur J Pharmacol 2001, 425(2):135-139.
40.Wise C, Drabkin D: Degradation of haemoglobin and hemin to biliverdin by a new cell-free system obtained from the hemophagous organ of dog placenta. Fed Proc 1964, 23:323.
41.Tenhunen R, Marver HS, Schmid R: The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A 1968, 61(2):748-755.
42.Tenhunen R, Marver HS, Schmid R: Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 1969, 244(23):6388-6394.
43.Tenhunen R, Marver HS, Schmid R: The enzymatic conversion of hemoglobin to bilirubin. Trans Assoc Am Physicians 1969, 82:363-371.
44.Keyse SM, Tyrrell RM: Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci U S A 1989, 86(1):99-103.
45.Morse D, Choi AM: Heme oxygenase-1: the "emerging molecule" has arrived. Am J Respir Cell Mol Biol 2002, 27(1):8-16.
46.Oberle S, Schwartz P, Abate A, Schroder H: The antioxidant defense protein ferritin is a novel and specific target for pentaerithrityl tetranitrate in endothelial cells. Biochem Biophys Res Commun 1999, 261(1):28-34.
47.Otterbein LE, Choi AM: Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 2000, 279(6):L1029-1037.
48.Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, Choi AM: Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000, 6(4):422-428.
49.Yesilkaya A, Altinayak R, Korgun DK: The antioxidant effect of free bilirubin on cumene-hydroperoxide treated human leukocytes. Gen Pharmacol 2000, 35(1):17-20.
50.Marks GS, Brien JF, Nakatsu K, McLaughlin BE: Does carbon monoxide have a physiological function? Trends Pharmacol Sci 1991, 12(5):185-188.
51.Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH: Carbon monoxide: a putative neural messenger. Science 1993, 259(5093):381-384.
52.Maines M: Carbon monoxide: An emerging regulator of cGMP in the brain. Mol Cell Neurosci 1993, 4:389-397.
53.Furchgott RF, Jothianandan D: Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 1991, 28(1-3):52-61.
54.Motterlini R, Gonzales A, Foresti R, Clark JE, Green CJ, Winslow RM: Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res 1998, 83(5):568-577.
55.Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, Soares MP: Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000, 192(7):1015-1026.
56.Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN: Bilirubin is an antioxidant of possible physiological importance. Science 1987, 235(4792):1043-1046.
57.Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R: Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 2000, 278(2):H643-651.
58.Vachharajani TJ, Work J, Issekutz AC, Granger DN: Heme oxygenase modulates selectin expression in different regional vascular beds. Am J Physiol Heart Circ Physiol 2000, 278(5):H1613-1617.
59.Vile GF, Tyrrell RM: Oxidative stress resulting from ultraviolet A irradiation of human skin fibroblasts leads to a heme oxygenase-dependent increase in ferritin. J Biol Chem 1993, 268(20):14678-14681.
60.Eisenstein RS, Garcia-Mayol D, Pettingell W, Munro HN: Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc Natl Acad Sci U S A 1991, 88(3):688-692.
61.Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, Vercellotti GM: Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 1992, 267(25):18148-18153.
62.McCoubrey WK, Jr., Huang TJ, Maines MD: Heme oxygenase-2 is a hemoprotein and binds heme through heme regulatory motifs that are not involved in heme catalysis. J Biol Chem 1997, 272(19):12568-12574.
63.Hayashi S, Omata Y, Sakamoto H, Higashimoto Y, Hara T, Sagara Y, Noguchi M: Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene 2004, 336(2):241-250.
64.Maines MD: The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997, 37:517-554.
65.Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999, 103(1):129-135.
66.Poss KD, Tonegawa S: Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A 1997, 94(20):10925-10930.
67.Lee TS, Chau LY: Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002, 8(3):240-246.
68.Inoue S, Suzuki M, Nagashima Y, Suzuki S, Hashiba T, Tsuburai T, Ikehara K, Matsuse T, Ishigatsubo Y: Transfer of heme oxygenase 1 cDNA by a replication-deficient adenovirus enhances interleukin 10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice. Hum Gene Ther 2001, 12(8):967-979.
69.Hashiba T, Suzuki M, Nagashima Y, Suzuki S, Inoue S, Tsuburai T, Matsuse T, Ishigatubo Y: Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice. Gene Ther 2001, 8(19):1499-1507.
70.Soares MP, Lin Y, Anrather J, Csizmadia E, Takigami K, Sato K, Grey ST, Colvin RB, Choi AM, Poss KD et al: Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 1998, 4(9):1073-1077.
71.Christou H, Morita T, Hsieh CM, Koike H, Arkonac B, Perrella MA, Kourembanas S: Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 2000, 86(12):1224-1229.
72.Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, Perrella MA, Mitsialis SA, Kourembanas S: Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci U S A 2001, 98(15):8798-8803.
73.Lai IR, Ma MC, Chen CF, Chang KJ: The protective role of heme oxygenase-1 on the liver after hypoxic preconditioning in rats. Transplantation 2004, 77(7):1004-1008.
74.Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, Ith B, Melo LG, Zhang L, Ingwall JS et al: Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 2001, 89(2):168-173.
75.Wang XH, Wang K, Zhang F, Li XC, Qian XF, Cheng F, Li GQ, Fan Y: Alleviating ischemia-reperfusion injury in aged rat liver by induction of heme oxygenase-1. Transplant Proc 2004, 36(10):2917-2923.
76.Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, Zhao D, Zaky J, Melinek J, Lassman CR et al: Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 1999, 104(11):1631-1639.
77.Elbirt KK, Bonkovsky HL: Heme oxygenase: recent advances in understanding its regulation and role. Proc Assoc Am Physicians 1999, 111(5):438-447.
78.Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, Abraham NG: Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci U S A 1994, 91(13):5987-5991.
79.Choi AM, Alam J: Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 1996, 15(1):9-19.
80.Alam J, Cai J, Smith A: Isolation and characterization of the mouse heme oxygenase-1 gene. Distal 5' sequences are required for induction by heme or heavy metals. J Biol Chem 1994, 269(2):1001-1009.
81.Camhi SL, Alam J, Otterbein L, Sylvester SL, Choi AM: Induction of heme oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1 activation. Am J Respir Cell Mol Biol 1995, 13(4):387-398.
82.Lee PJ, Alam J, Sylvester SL, Inamdar N, Otterbein L, Choi AM: Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury. Am J Respir Cell Mol Biol 1996, 14(6):556-568.
83.Lee PJ, Camhi SL, Chin BY, Alam J, Choi AM: AP-1 and STAT mediate hyperoxia-induced gene transcription of heme oxygenase-1. Am J Physiol Lung Cell Mol Physiol 2000, 279(1):L175-182.
84.Rensing H, Jaeschke H, Bauer I, Patau C, Datene V, Pannen BH, Bauer M: Differential activation pattern of redox-sensitive transcription factors and stress-inducible dilator systems heme oxygenase-1 and inducible nitric oxide synthase in hemorrhagic and endotoxic shock. Crit Care Med 2001, 29(10):1962-1971.
85.Brand K, Page S, Walli AK, Neumeier D, Baeuerle PA: Role of nuclear factor-kappa B in atherogenesis. Exp Physiol 1997, 82(2):297-304.
86.Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ: Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 1993, 91(6):2572-2579.
87.Alam J, Stewart D, Touchard C, Boinapally S, Choi AM, Cook JL: Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 1999, 274(37):26071-26078.
88.Alam J, Wicks C, Stewart D, Gong P, Touchard C, Otterbein S, Choi AM, Burow ME, Tou J: Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. J Biol Chem 2000, 275(36):27694-27702.
89.He CH, Gong P, Hu B, Stewart D, Choi ME, Choi AM, Alam J: Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J Biol Chem 2001, 276(24):20858-20865.
90.Elbirt KK, Whitmarsh AJ, Davis RJ, Bonkovsky HL: Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases. J Biol Chem 1998, 273(15):8922-8931.
91.Zhang X, Bedard EL, Potter R, Zhong R, Alam J, Choi AM, Lee PJ: Mitogen-activated protein kinases regulate HO-1 gene transcription after ischemia-reperfusion lung injury. Am J Physiol Lung Cell Mol Physiol 2002, 283(4):L815-829.
92.Ryter SW, Xi S, Hartsfield CL, Choi AM: Mitogen activated protein kinase (MAPK) pathway regulates heme oxygenase-1 gene expression by hypoxia in vascular cells. Antioxid Redox Signal 2002, 4(4):587-592.
93.Terry CM, Clikeman JA, Hoidal JR, Callahan KS: TNF-alpha and IL-1alpha induce heme oxygenase-1 via protein kinase C, Ca2+, and phospholipase A2 in endothelial cells. Am J Physiol 1999, 276(5 Pt 2):H1493-1501.
94.Santoro MG: Heat shock factors and the control of the stress response. Biochem Pharmacol 2000, 59(1):55-63.
95.Morimoto RI, Santoro MG: Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat Biotechnol 1998, 16(9):833-838.
96.Petrache I, Otterbein LE, Alam J, Wiegand GW, Choi AM: Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts. Am J Physiol Lung Cell Mol Physiol 2000, 278(2):L312-319.
97.Dore S, Takahashi M, Ferris CD, Zakhary R, Hester LD, Guastella D, Snyder SH: Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci U S A 1999, 96(5):2445-2450.
98.Tobiasch E, Gunther L, Bach FH: Heme oxygenase-1 protects pancreatic beta cells from apoptosis caused by various stimuli. J Investig Med 2001, 49(6):566-571.
99.Brouard S, Berberat PO, Tobiasch E, Seldon MP, Bach FH, Soares MP: Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. J Biol Chem 2002, 277(20):17950-17961.
100.Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, Nabel EG: Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 2001, 7(6):693-698.
101.Inguaggiato P, Gonzalez-Michaca L, Croatt AJ, Haggard JJ, Alam J, Nath KA: Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int 2001, 60(6):2181-2191.
102.Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B: Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 1996, 10(15):1945-1952.
103.Megyesi J, Safirstein RL, Price PM: Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 1998, 101(4):777-782.
104.Sikorski EM, Hock T, Hill-Kapturczak N, Agarwal A: The story so far: Molecular regulation of the heme oxygenase-1 gene in renal injury. Am J Physiol Renal Physiol 2004, 286(3):F425-441.
105.Nath KA, Balla G, Vercellotti GM, Balla J, Jacob HS, Levitt MD, Rosenberg ME: Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 1992, 90(1):267-270.
106.Nimura T, Weinstein PR, Massa SM, Panter S, Sharp FR: Heme oxygenase-1 (HO-1) protein induction in rat brain following focal ischemia. Brain Res Mol Brain Res 1996, 37(1-2):201-208.
107.Panahian N, Yoshiura M, Maines MD: Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J Neurochem 1999, 72(3):1187-1203.
108.Stewart PL, Fuller SD, Burnett RM: Difference imaging of adenovirus: bridging the resolution gap between X-ray crystallography and electron microscopy. Embo J 1993, 12(7):2589-2599.
109.Bramson JL, Graham FL, Gauldie J: The use of adenoviral vectors for gene therapy and gene transfer in vivo. Curr Opin Biotechnol 1995, 6(5):590-595.
110.Greber UF, Willetts M, Webster P, Helenius A: Stepwise dismantling of adenovirus 2 during entry into cells. Cell 1993, 75(3):477-486.
111.Moran E: Interaction of adenoviral proteins with pRB and p53. Faseb J 1993, 7(10):880-885.
112.Haddada H, Cordier L, Perricaudet M: Gene therapy using adenovirus vectors. Curr Top Microbiol Immunol 1995, 199 (Pt 3):297-306.
113.He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998, 95(5):2509-2514.
114.McGrory WJ, Bautista DS, Graham FL: A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 1988, 163(2):614-617.
115.Weatherall DJ: Scope and limitations of gene therapy. Br Med Bull 1995, 51(1):1-11.
116.Robbins PD, Ghivizzani SC: Viral vectors for gene therapy. Pharmacol Ther 1998, 80(1):35-47.
117.Ish-Horowicz D, Burke JF: Rapid and efficient cosmid cloning. Nucleic Acids Res 1981, 9(13):2989-2998.
118.Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979, 76(9):4350-4354.
119.Kountouras J, Billing BH, Scheuer PJ: Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984, 65(3):305-311.
120.Graham FL, Smiley J, Russell WC, Nairn R: Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977, 36(1):59-74.
121.Dai J, Rabie AB, Hagg U, Xu R: Alternative gene therapy strategies for the repair of craniofacial bone defects. Curr Gene Ther 2004, 4(4):469-485.
122.Cao B, Mytinger JR, Huard J: Adenovirus mediated gene transfer to skeletal muscle. Microsc Res Tech 2002, 58(1):45-51.
123.Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK, Chau LY: Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2001, 104(13):1519-1525.
124.Jooss K, Chirmule N: Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy. Gene Ther 2003, 10(11):955-963.
125.Volpers C, Kochanek S: Adenoviral vectors for gene transfer and therapy. J Gene Med 2004, 6 Suppl 1:S164-171.
126.Ilan Y, Saito H, Thummala NR, Chowdhury NR: Adenovirus-mediated gene therapy of liver diseases. Semin Liver Dis 1999, 19(1):49-59.
127.Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW: Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275(5304):1320-1323.
128.Wickham TJ, Mathias P, Cheresh DA, Nemerow GR: Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993, 73(2):309-319.
129.Smith T, Idamakanti N, Kylefjord H, Rollence M, King L, Kaloss M, Kaleko M, Stevenson SC: In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor. Mol Ther 2002, 5(6):770-779.
130.Einfeld DA, Schroeder R, Roelvink PW, Lizonova A, King CR, Kovesdi I, Wickham TJ: Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions. J Virol 2001, 75(23):11284-11291.
131.Martin K, Brie A, Saulnier P, Perricaudet M, Yeh P, Vigne E: Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism. Mol Ther 2003, 8(3):485-494.
132.Dechecchi MC, Melotti P, Bonizzato A, Santacatterina M, Chilosi M, Cabrini G: Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J Virol 2001, 75(18):8772-8780.
133.Dechecchi MC, Tamanini A, Bonizzato A, Cabrini G: Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology 2000, 268(2):382-390.
134.Cichon G, Boeckh-Herwig S, Kuemin D, Hoffmann C, Schmidt HH, Wehnes E, Haensch W, Schneider U, Eckhardt U, Burger R et al: Titer determination of Ad5 in blood: a cautionary note. Gene Ther 2003, 10(12):1012-1017.
135.Sokol RJ, Winklhofer-Roob BM, Devereaux MW, McKim JM, Jr.: Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology 1995, 109(4):1249-1256.
136.Pastor A, Collado PS, Almar M, Gonzalez-Gallego J: Antioxidant enzyme status in biliary obstructed rats: effects of N-acetylcysteine. J Hepatol 1997, 27(2):363-370.
137.Alptekin N, Mehmetcik G, Uysal M, Aykac-toker G: Evidence for oxidative stress in the hepatic mitochondria of bile duct ligated rats. Pharmacol Res 1997, 36(3):243-247.
138.Brasile L, Buelow R, Stubenitsky BM, Kootstra G: Induction of heme oxygenase-1 in kidneys during ex vivo warm perfusion. Transplantation 2003, 76(8):1145-1149.
139.Abraham NG, Kappas A: Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 2005, 39(1):1-25.
140.Tephly TR, Hasegawa E, Baron J: Effect of drugs on heme synthesis in the liver. Metabolism 1971, 20(2):200-214.
141.Redaelli CA, Tian YH, Schaffner T, Ledermann M, Baer HU, Dufour JF: Extended preservation of rat liver graft by induction of heme oxygenase-1. Hepatology 2002, 35(5):1082-1092.
142.Dorman RB, Bajt ML, Farhood A, Mayes J, Jaeschke H: Heme oxygenase-1 induction in hepatocytes and non-parenchymal cells protects against liver injury during endotoxemia. Comp Hepatol 2004, 3 Suppl 1:S42.
143.Tsai LY, Lee KT, Liu TZ: Evidence for accelerated generation of hydroxyl radicals in experimental obstructive jaundice of rats. Free Radic Biol Med 1998, 24(5):732-737.
144.Akagi K, Sandig V, Vooijs M, Van der Valk M, Giovannini M, Strauss M, Berns A: Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Res 1997, 25(9):1766-1773.
145.Yang Y, Jooss KU, Su Q, Ertl HC, Wilson JM: Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther 1996, 3(2):137-144.
146.Rodrigues CM, Fan G, Wong PY, Kren BT, Steer CJ: Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998, 4(3):165-178.
147.Sass G, Soares MC, Yamashita K, Seyfried S, Zimmermann WH, Eschenhagen T, Kaczmarek E, Ritter T, Volk HD, Tiegs G: Heme oxygenase-1 and its reaction product, carbon monoxide, prevent inflammation-related apoptotic liver damage in mice. Hepatology 2003, 38(4):909-918.
148.Ding WX, Yin XM: Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med 2004, 8(4):445-454.
149.Heneghan MA, Harrison PM: Pathogenesis of ascites in cirrhosis and portal hypertension. Med Sci Monit 2000, 6(4):807-816.
150.Mancinella A: [The hepatorenal syndrome: etiopathogenetic, clinical and therapeutic considerations]. Clin Ter 1976, 79(6):583-590.
151.Gaines DI, Fallon MB: Hepatopulmonary syndrome. Liver Int 2004, 24(5):397-401.
152.Miyazono M, Garat C, Morris KG, Jr., Carter EP: Decreased renal heme oxygenase-1 expression contributes to decreased renal function during cirrhosis. Am J Physiol Renal Physiol 2002, 283(5):F1123-1131.
|